FDA Announces Final Rule on LDT Regulation
The U.S. FDA finalized a rule regarding its oversight of LDTs to make explicit that IVDs are considered devices under the FD&C Act.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Compliance |
The U.S. FDA finalized a rule regarding its oversight of LDTs to make explicit that IVDs are considered devices under the FD&C Act.
Read MorePosted by Andy Lundin | Apr 19, 2024 | Covid 19 |
The lab-developed test will help diagnose Long COVID and is aimed to provide accurate insights into personalized treatment approaches.
Read MorePosted by Andy Lundin | Apr 15, 2024 | Womens Health |
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read MorePosted by Andy Lundin | Apr 12, 2024 | Company News, Molecular Diagnostics |
The facility has been designed to manufacture the company’s Co-Dx Pro instrument and test cups for the new platform.
Read MorePosted by Chris Wolski | Apr 9, 2024 | Molecular Diagnostic Analyzers |
There is a potential to use T-cell diagnostics to diagnose underlying post-viral syndromes by measuring the bodies adaptive immune resistance.
Read More